Abstract
Purified preparations of human C'1 esterase, C'4, C'2, C'3, and C'5 were labeled with (125)I. Reaction mixtures were prepared containing a single labeled component and other unlabled components. After incubation at 37 degrees C for 10 min at pH 7.4 in the presence of 5 x 10(-4)M Mg(2+), they were adjusted to pH 3.5 and subjected to sucrose density gradient ultracentrifugation and gel filtration at pH 3.5. In all cases, an activity capable of contracting guinea pig ileum with tachyphylaxis was obtained in low molecular weight fractions. However, these fractions were labeled only when (125)I-C'3 was employed, indicating that biological activity was associated with a cleavage product of C'3. This fragment has been designated F(a)C'3 in a nomenclature consistent with that of immunoglobulin degradation products. The much larger, residual portion of the C'3 molecule has been designated F(b)C'3. The biochemical characteristics of generation of F(a)C'3 were consistent with a mechanism involving action of C'1 esterase on C'4 and C'2, activation of C'2, and cleavage of C'3. F(a)C'3 had a molecular weight by gel filtration techniques of 6800 or less. It was thermostable and susceptible to inactivation by endo- and exopeptidases. The isolated fragment possessed all of the biological properties of unfractionated mixtures of C'1 esterase, C'4, C'2, and C'3. In addition to contraction of guinea pig ileum, these included failure to contract rat uterus, enhancement of vascular permeability in guinea pig skin, degranulation of mast cells in guinea pig mesentery, and release of histamine from rat peritoneal mast cells. F(a)C'3 did not cross-desensitize guinea pig ileum to rat agar anaphylatoxin and vice versa. The existence of different protein fragments with anaphylatoxin properties has been discussed. Distinctive characteristics of F(a)C'3 from classical anaphylatoxin generated by treatment of fresh rat serum with agar have been indicated.
MeSH Terms
Anaphylaxis
Animals
Chromatography, Gel
Complement System Proteins/analysis,physiology
Esterases/pharmacology
Horses
Humans
Hydrogen-Ion Concentration
Immune Sera
Immunochemistry
Immunoelectrophoresis
In Vitro Techniques
Inflammation/immunology
Iodine Radioisotopes
Muscle Contraction/drug effects
Muscle, Smooth/drug effects
Peptide Hydrolases/pharmacology
Rabbits
Tachyphylaxis/physiology
Toxins, Biological
Chemicals
Immune Sera
Iodine Radioisotopes
Toxins, Biological
Complement System Proteins
Esterases
Peptide Hydrolases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
da Silva W D
Eisele J W
Lepow I H
References (23)
23 references, click to expand
-
Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement.
J Immunol. 1966 Nov;97(5):680-5
PMID: 5926456
-
Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
J Exp Med. 1967 Feb 1;125(2):359-80
PMID: 6019133
-
A method for determining the sedimentation behavior of enzymes: application to protein mixtures.
J Biol Chem. 1961 May;236:1372-9
PMID: 13767412
-
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
J Exp Med. 1965 Aug 1;122:277-98
PMID: 14316946
-
ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.
J Exp Med. 1963 Sep 1;118:447-66
PMID: 14078003
-
STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.
J Immunol. 1964 Mar;92:456-67
PMID: 14128991
-
Release of histamine from mast cells by antigen-antibody reactions in vitro.
Aust J Exp Biol Med Sci. 1960 Apr;38:147-51
PMID: 13794069
-
High specific activity iodination of gamma-globulin with iodine-131 monochloride.
Cancer Res. 1960 Nov;20:1495-1500
PMID: 13713200
-
THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.
J Exp Med. 1964 Apr 1;119:593-613
PMID: 14151101
-
Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.
J Exp Med. 1967 May 1;125(5):921-46
PMID: 4960742
-
Reduction of tissue histamine by compound 48/80.
J Physiol. 1953 Jun 29;120(4):550-68
PMID: 13070227
-
Action of anaphylactic shock and anaphylatoxin on mast cells and histamine in rats.
Br J Pharmacol Chemother. 1957 Dec;12(4):453-6
PMID: 13489173
-
[ON THE NATURE OF ANAPHYLATOXIN].
Hoppe Seylers Z Physiol Chem. 1964;337:269-76
PMID: 14316921
-
The gel-filtration behaviour of proteins related to their molecular weights over a wide range.
Biochem J. 1965 Sep;96(3):595-606
PMID: 5862401
-
C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.
J Exp Med. 1965 May 1;121:819-33
PMID: 14280442
-
Anaphylatoxin in its relation to the complement system.
Science. 1967 Mar 3;155(3766):1122-3
PMID: 6021911
-
Formation of anaphylatoxin in rat plasma, a specific enzymic process.
Biochem Pharmacol. 1966 Jul;15(7):905-14
PMID: 5967903
-
The anti-anaphylactic and histamine-releasing properties of the antihistamines. Their effect on the mast cells.
Br J Pharmacol Chemother. 1960 Sep;15:396-404
PMID: 13773171
-
COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE.
J Exp Med. 1963 Nov 1;118:681-98
PMID: 14087615
-
Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum.
Br J Exp Pathol. 1955 Feb;36(1):71-81
PMID: 14351639
-
Anaphylatoxin formation by purified human C'1 esterase.
J Immunol. 1965 Dec;95(6):1080-9
PMID: 4158798
-
Protein measurement with the Folin phenol reagent.
J Biol Chem. 1951 Nov;193(1):265-75
PMID: 14907713
-
ENHANCEMENT OF VASCULAR PERMEABILITY BY MIXTURES OF C'1 ESTERASE AND NORMAL SERUM.
Proc Soc Exp Biol Med. 1964 Jun;116:280-3
PMID: 14193359